163 related articles for article (PubMed ID: 37558659)
1. Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis.
Yamada T; Hiramoto N; Mori T; Yamashita D; Tai Y; Yamamoto R; Nishikubo M; Maruoka H; Sakamoto K; Takeuchi K; Nannya Y; Ogawa S; Ishikawa T
Blood Cancer J; 2023 Aug; 13(1):119. PubMed ID: 37558659
[No Abstract] [Full Text] [Related]
2. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.
Khanlari M; Yin CC; Takahashi K; Lachowiez C; Tang G; Loghavi S; Bah I; Wang W; Konoplev S; Medeiros LJ; Pemmaraju N; Khoury JD; Wang SA
Leukemia; 2022 May; 36(5):1343-1350. PubMed ID: 35279700
[TBL] [Abstract][Full Text] [Related]
3. Blastic plasmacytoid dendritic cell neoplasm of the skin associated with myelodysplastic syndrome.
Kong QT; Zhang M; Sang H; Chen J; Yan W; Hu W; Deng D; Xie Q
Dermatol Online J; 2014 Dec; 21(3):. PubMed ID: 25780974
[TBL] [Abstract][Full Text] [Related]
4. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Patel JL; Shetty S; Salama ME
Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid Dendritic Cell Dermatosis Associated to Myeloproliferative/Myelodysplastic Neoplasms.
Machan S; Alonso-Dominguez JM; Sánchez García FJ; Nieves Salgado R; Soto C; Castro Y; Pajares R; Manso R; Santonja C; Serrano Del Castillo C; Piris MA; Requena L; Rodríguez Pinilla SM
Am J Surg Pathol; 2022 Dec; 46(12):1623-1632. PubMed ID: 36001453
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis in different foci revealing the clonal evolution of blastic plasmacytoid dendritic cell neoplasm.
Zhang X; Zhu Y; Yang M; Wang L; Jin J; Yu W
Leuk Lymphoma; 2021 Apr; 62(4):988-991. PubMed ID: 33174506
[No Abstract] [Full Text] [Related]
7. A neonatal case of congenital blastic plasmacytoid dendritic cell neoplasm with KMT2C gene duplication.
Li J; Wang J; Rong L; Zhou L; Hong Y; Zhu L; Fang Y
Ann Hematol; 2023 Jan; 102(1):227-229. PubMed ID: 36348067
[No Abstract] [Full Text] [Related]
8. Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome.
Yasuda H; Takaku T; Tomomatsu J; Hosone M; Tanaka H; Komatsu N
Intern Med; 2014; 53(23):2717-20. PubMed ID: 25447656
[TBL] [Abstract][Full Text] [Related]
9. Liposomal Daunorubicin and Cytarabine, a Potential Therapy for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Ashok Kumar P; Ombada M; Pemmasani G; Tambe A; Banki K; Gentile T
J Investig Med High Impact Case Rep; 2022; 10():23247096221127114. PubMed ID: 36341907
[TBL] [Abstract][Full Text] [Related]
10. Blastic plasmacytoid dendritic cell neoplasm in ocular adnexa.
Zandi S; Ghaffar H
Blood; 2022 Oct; 140(14):1656. PubMed ID: 36201335
[No Abstract] [Full Text] [Related]
11. Unifocal cutaneous blastic plasmacytoid dendritic cell neoplasm with a favorable response following high-dose radiotherapy alone.
Higgins MJ; Harrop S; Lade S; Prince HM; McCormack C; Campbell BA
Leuk Lymphoma; 2022 Dec; 63(12):3004-3007. PubMed ID: 35904420
[No Abstract] [Full Text] [Related]
12. [Blastic plasmacytoid dentritic cell neoplasm with myeloproliferative neoplasms:a case report].
Han J; Li Y; Wang PJ; Shi CL; Ding B; Wang L
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):256. PubMed ID: 28395455
[No Abstract] [Full Text] [Related]
13. [Pathomorphological and clinical characteristics of blastic plasmocytoid dendritic cell neoplasm. Case report].
Sherstnev AA; Kovrigina AM; Solovyova TI; Moiseeva TN
Ter Arkh; 2022 Aug; 94(7):891-896. PubMed ID: 36286948
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: How to Treat?
Tomé A; Pragosa H; Caldas G; Lacerda A; Pereira F
J Pediatr Hematol Oncol; 2017 May; 39(4):323. PubMed ID: 28267092
[No Abstract] [Full Text] [Related]
15. In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
Angelot-Delettre F; Roggy A; Frankel AE; Lamarthee B; Seilles E; Biichle S; Royer B; Deconinck E; Rowinsky EK; Brooks C; Bardet V; Benet B; Bennani H; Benseddik Z; Debliquis A; Lusina D; Roussel M; Solly F; Ticchioni M; Saas P; Garnache-Ottou F
Haematologica; 2015 Feb; 100(2):223-30. PubMed ID: 25381130
[TBL] [Abstract][Full Text] [Related]
16. Immunoblastoid blastic plasmacytoid dendritic cell neoplasm with MYC rearrangement.
Yu YT; Chang KC
Blood; 2022 Apr; 139(14):2257. PubMed ID: 35389436
[No Abstract] [Full Text] [Related]
17. Pediatric Case of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rare Entity.
Gündüz M; Tuğcu D; Ünüvar A; Yegen G; Büyükbabani N; Öztürk Sarı Ş
Turk J Haematol; 2022 Feb; 39(1):68-69. PubMed ID: 34753276
[No Abstract] [Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
Lim MS; Lemmert K; Enjeti A
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
[TBL] [Abstract][Full Text] [Related]
19. Blastic plasmacytoid dendritic cell neoplasm. A study of three cases.
Sitges M; Vives S; Ribera JM
Med Clin (Barc); 2020 Jun; 154(12):524-525. PubMed ID: 31350059
[No Abstract] [Full Text] [Related]
20. [Enhancer hijacking via disease-specific chromosomal translocation in blastic plasmacytoid dendritic cell neoplasm].
Kubota S
Rinsho Ketsueki; 2020; 61(1):47-51. PubMed ID: 32023603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
